TheEdgeResearch
Home / Stocks / SFOSF

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$1.88 ▲ +0.00%
Market Cap
$4.96B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.44
52-Wk Range
1.875-3.3
CEO
Yi Liu
Country
CN
Currency
USD

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Shanghai, SH, CN. The stock last traded at $1.88, up 0.00% on the session, giving a market capitalisation of $4.96B. On trailing twelve-month figures it carries a trailing P/E of 15.26, a net margin of 8.2%. Its beta of 0.44 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
15.26
Price / Sales
1.27
Price / Book
1.07
EV / EBITDA
14.89
Gross margin
49.3%
Operating margin
7.9%
Net margin
8.2%
Return on equity
—
Debt / equity
0.82
Current ratio
0.98
Dividend yield
1.9%
Payout ratio
30.9%
Company profile
Exchange
Other OTC
Employees
40,603
IPO date
2014-04-21
Headquarters
Shanghai, SH, CN
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

More research on SFOSF
SFOSF technical analysis SFOSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →